Bringing the fundamentals into focus…
Back to Protagonist Therapeutics, Inc.
How Protagonist Therapeutics, Inc. stacks up
PTGX · against 1,216 other Healthcare companies
Growth
83/ 100
Near the top of its peers.
Ranked #202 of 1,217 · scores higher than 83% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 80–89, including PTGX · Click a bar to see the companies
Why growth scores 83?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its revenue growth, 3-year revenue growth and earnings per share growth, which are stronger than most Healthcare peers.
- faster growth in earnings per share: stronger than 78% of peers. Earnings per share growth: 53.2% vs peer median 9.8%
- faster revenue growth over three years: stronger than 81% of peers. 3-year revenue growth: 20.1% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 87% of peers. Revenue growth: 34.8% vs peer median 6.1%
Metric by metric
Position: dot = PTGX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | PTGX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 34.8% | 6.1% | 87% | 33% | |
| Earnings per share growthHigher is better · 682 reported | 53.2% | 9.7% | 78% | 33% | |
| 3-year revenue growthHigher is better · 1,192 reported | 20.1% | 5.8% | 81% | 33% |
Ranking by growth score
Top 5 and the companies ranked around PTGX| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 202 | 1.8B USD | 83 | 80 | |
| 202 | 4.2B USD | 83 | 41 | |
| 202 | 1.26T INR (≈$15.1B) | 83 | 63 | |
| 202 | 1.4B USD | 83 | 53 | |
| 202 | 9.1B USD | 83 | 74 | |
| 202 | 2.0B USD | 83 | 44 | |
| 214 | 8.1B HKD (≈$1.0B) | 82 | 70 | |
| 214 | 15.4B HKD (≈$2.0B) | 82 | 44 | |
| 214 | 67.60T KRW (≈$48.7B) | 82 | 72 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score